LIGAND PHARMACEUTICALS INC (LGND) Total liabilities 2016–2025
LIGAND PHARMACEUTICALS INC (LGND) total liabilities at each fiscal year-end, per SEC filings.
$543.4MFY2025 · since FY2016: $230.7M → $543.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $543.4M | +388.1% |
| FY2024 | $111.3M | +29.0% |
| FY2023 | $86.3M | -47.8% |
| FY2022 | $165.2M | -65.3% |
| FY2021 | $476.4M | -27.0% |
| FY2020 | $652.8M | -10.3% |
| FY2019 | $727.7M | +4.0% |
| FY2018 | $699.9M | +177.3% |
| FY2017 | $252.4M | +9.4% |
| FY2016 | $230.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice